The percentage of deceased donors expected to have one or more of the unacceptable antigens indicated on the waiting list for the candidate. The CPRA is derived from HLA antigen/allele group and haplotype frequencies for the different ethnic groups in proportion to their representation in the national deceased donor population.
(OPTN Policy Definitions May 2021)
Glossary Term
CPRA
Calculated Panel Reactive Antibody